AI assistant
Ascelia Pharma Major Shareholding Notification 2020
3132_iss_2020-01-27_2cdd6c52-d237-46fd-a143-c32e605dbdcf.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Ascelia Pharma AB
Holder
Eiffel Investment Group SAS
Instrument
| Instrument | Ordinary shares SE0010573113 | |
|---|---|---|
| Before the transaction | ||
| Shares | 1,174,796 | |
| Voting rights | 1,174,796 | |
| Transaction | ||
| Reason for major shareholding notification Sell | ||
| Date | 22/01/2020 | |
| Limit for number of shares | 5 % | |
| Limit for number of votes | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 1,174,408 | |
| Directly held voting rights | 1,174,408 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 4.99984 % | |
| Directly held voting rights | 4.99984 % | |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 4.99984 % | 1,174,408 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 4.99984 % | 1,174,408 |
| Group total holdings |
||
| Voting rights 1,174,408 |
||
| Percentage of voting rights 4.99984 | ||
| Published | ||
| 27/01/2020 09:22 |
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25